<sup id="eegqs"></sup>
<acronym id="eegqs"><noscript id="eegqs"></noscript></acronym>
<acronym id="eegqs"><noscript id="eegqs"></noscript></acronym>
<sup id="eegqs"><wbr id="eegqs"></wbr></sup>
<sup id="eegqs"><noscript id="eegqs"></noscript></sup>
<sup id="eegqs"><noscript id="eegqs"></noscript></sup>
<sup id="eegqs"><wbr id="eegqs"></wbr></sup>
<sup id="eegqs"><noscript id="eegqs"></noscript></sup>

新聞中心

GMP中要求有哪些SOP(內部學(xué)習)

發(fā)布日期:2015/03/11


 

Which SOPs arerequired by GMP?

GMP要求有哪些SOP?

 

The ECA Academy is receiving a lot of questions on SOPs (Standard Operating Procedures)needed in a GMP environment. The most interesting is the one on which SOPs are required by law. Here is an Overview:

ECA學(xué)會(huì )收到大量GMP環(huán)境下所需SOP(標準操作規程)的問(wèn)題,其中最有意思的問(wèn)題是法規要求哪些SOP。以下是一個(gè)概覽:

 

U.S. Food and Drug Administration (FDA): 美國FDA

 

A three year old Notice focusing on specific record keeping requirements in the Federal Register also gives a very good summary of SOPs required by 21 CFR Part 211:
三年前,在聯(lián)邦注冊上有一個(gè)關(guān)于記錄管理要求方面的通知對于21CFR211部分要求有哪些SOP做了一個(gè)很好的總結:
 

Written procedures (standard operating procedures - SOPs),are required for many Part 211 records. The current SOP requirements were initially provided in a final rule published in the Federal Register of September 29, 1978 (43 FR 45014), and are now an integral and familiar part of the drug manufacturing process.

“許多第211部分的記錄要求具有書(shū)面程序(標準操作規程SOP)?,F行SOP要求最初是在聯(lián)邦注冊1978929日(43FR45014)中公布的,現在已經(jīng)成為藥品生產(chǎn)過(guò)程中必要的類(lèi)似部分”。

 

  • The 25 SOPs provisions under Part 211 include:

  • 211部分中25個(gè)SOP條款包括

  • Section211.22(d)-Responsibilities and procedures of the quality control unit;

  • 211.22(d)- 質(zhì)量控制部門(mén)的職責和程序

  • Section211.56(b)-Sanitation procedures

  • 211.56(b) - 消毒程序

  • Section211.56(c)-Use of suitable rodenticides, insecticides, fungicides, sanitizing agents;

  • 211.56(c)---使用適當殺蟲(chóng)劑、滅鼠藥、殺真菌劑、消毒劑

  • Section211.67(b)-Cleaning and maintenance of equipment;

  • 211.67(b)----設備的清潔和維護

  • Section211.68(a)-Proper performance of automatic, mechanical, and electronic equipment;

  • 211.68(a)----自動(dòng)化、機械化和電子設備具備適當性能

  • Section211.80(a)-Receipt, identification, storage, handling, sampling, testing, and approval or rejection of components and drug product containers or closures;

  • 211.80(a)---部件和藥品容器密閉材料的接收、鑒別、存貯、處置、取樣、測試和批準或拒收

  • Section211.94(d)-Standards or specifications, methods of testing, and methods of cleaning, sterilizing, and processing to remove pyrogenic properties for drug product containers and closures;

  • 211.80(d)---藥品容器密閉材料的規格或質(zhì)量標準、檢驗方法、清潔方法、滅菌方法及清除熱原

  • Section211.100(a)-Production and process control;

  • 211.100(a)---生產(chǎn)和工藝控制

  • Section211.110(a)-Sampling and testing of in-process materials and drug products;

  • 211.110(a)---中控和成品取樣和檢測

  • Section211.113(a)-Prevention of objectionable microorganisms in drug products not required to be sterile;

  • 211.113(a)----非無(wú)菌藥品中防止有害微生物

  • Section211.113(b)-Prevention of microbiological contamination of drug product spurporting to be sterile, including validation of any sterilization process;

  • 211.113(b)---無(wú)菌藥品中防止微生物污染,包括所有無(wú)菌工藝的驗證

  • Section211.115(a)-System for reprocessing batches that do not conform to standards or specifications, to insure that reprocessed batches conform with all established standards, specifications, and characteristics;

  • 211.115(a)----不符合質(zhì)量標準的批準的返工管理,以保證返工后批次符合所有既定標準、質(zhì)量規格和特性

  • Section211.122(a)-Receipt, identification, storage, handling, sampling, examination and/or testing of labeling and packaging materials;

  • 211.122(a)---標簽和包裝材料的接收、鑒別、存貯、處置、取樣、檢查和/或檢測

  • Section211.125(f)-Control procedures for the issuance of labeling;

  • 211.125(f)---標簽發(fā)放控制程序

  • Section211.130-Packaging and label operations, prevention of mixup and cross contamination, identification and handling of filed drug product containers that are set aside and held in unlabeled condition, and identification of the drug product with a lot or control number that permits determination of the history of the manufacture and control of the batch;

  • 211.130---包裝和貼標操作、防止混淆和交叉污染、鑒別和處置已印制但棄置且無(wú)標識的藥品包材、采用批號或控制號鑒別藥品,使其可追溯生產(chǎn)和批控制歷史

  • Section211.142-Warehousing;

  • 211.142----倉庫管理

  • Section211.150-Distribution of drug products;

  • 211.150----藥品分銷(xiāo)

  • Section211.160-Laboratory controls;

  • 211.160----實(shí)驗室控制

  • Section211.165(c)-Testing and release for distribution;

  • 211.165(c)-----檢測和放行用于銷(xiāo)售

  • Section211.166(a)-Stability testing;

  • 211.166(a)---穩定性測試

  • Section211.167-Special testing requirements;

  • 211.167----特殊檢測要求

  • Section211.180(f)-Notification of responsible officials of investigations, recalls,reports of inspectional observations, and any regulatory actions relating to good manufacturing practice;

  • 211.180(f)----將調查、召回、檢查缺陷和所有與GMP相關(guān)的法規行動(dòng)通知相關(guān)官方

  • Section211.198(a)-Written and oral complaint procedures, including quality involving specifications failures, and serious and unexpected adverse drug experiences;


  • 杭州市余杭區星橋北路64號 1號樓201室(杭州)
    福建省三明市明溪縣經(jīng)濟開(kāi)發(fā)區D區39號(福建)   

    總          機:0598-2893888
    采購部直線(xiàn):0598-2812588


    郵    箱:purchase@freemindpharm.com(采購部)
    郵    箱:HR@freemindpharm.com(人力資源部)

           

    銷(xiāo)售部直線(xiàn):0598-2812288    
      Mr. 黃   手機:15306818081      QQ : 530739555
      郵箱:sales@freemindpharm.com
      Mr. 張   手機:13599397867     QQ:578610944 
      郵箱:info@freemindpharm.com

      藥用輔料國內制劑及研發(fā):Mr. 潘  18368006136 

    99久久麻豆AV色婷婷综合,国产最新精品SM调教视频,我的漂亮女房东完整版在线韩剧,偷窥美女洗澡一区二区三区
    建水县| 老河口市| 衡水市| 长顺县| 福清市| 眉山市| 玉屏| 临沧市| 阿合奇县| 和龙市| 建德市| 尚志市| 普洱| 玉门市| 阿图什市| 乐业县| 东乌珠穆沁旗| 平遥县| 垫江县| 佛山市| 清徐县| 清新县| 平谷区| 醴陵市| 澄江县| 法库县| 社旗县| 榆中县| 沁源县| 金山区| 南宁市| 韶山市| 雷州市| 阳新县| 淮阳县| 淅川县| 滨州市| 进贤县| 和林格尔县| 尚志市| 新闻| http://www.shaly007.com http://www.29886c.com http://www.57gjd.com http://www.cmwjj.com http://www.lyajl.com http://www.whhzyy.com